 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Four months of rifampicin monotherapy for latent tuberculosis infection in children |
| Chi Eun Oh, Dick Menzies |
|
Clin Exp Pediatr. 2022;65(5):214-221. Published online October 29, 2021 DOI: https://doi.org/10.3345/cep.2021.01186 |
|
Four months of rifampicin monotherapy for latent tuberculosis infection in children Clinical and Experimental Pediatrics. 2022;65(5):214-221  Four months of rifampicin for tuberculosis prevention treatment in children Journal of Infection and Chemotherapy. 2023;29(2):235 LOW INCIDENCE OF DRUG INDUCED HEPATITIS IN 4 MONTHS RIFAMPICIN REGIMEN FOR THE PREVENTIVE CHEMOTHERAPY OF LATENT TUBERCULOSIS INFECTION Respirology. 2018;23:206-207 Isoniazid/rifampicin preferable for latent tuberculosis infection PharmacoEconomics & Outcomes News. 2001;294(1):10-10 Acquired Resistance to Isoniazid During Isoniazid Monotherapy in a Subject with Latent Infection Following Household Rifampicin-Resistant Tuberculosis Contact: A Case Report Infection and Drug Resistance. 2021;Volume 14:1505-1509 Isoniazid + rifampicin for 4 months reduces tuberculosis incidence InPharma. 1989;690(1):7-8 Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection Journal of the American Academy of Dermatology. 2004;50(5):801 Personalized early diagnosis and prediction of the tuberculosis infection course in children identifying predictors of latent tuberculosis infection and tuberculosis Tuberculosis and Lung Diseases. 2021;99(1):33-39 Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates Infection. 2017;45(3):335-339 Latent tuberculosis infection: Opportunities and challenges Respirology. 2018;23(10):893-900 |
